Physician profile
Brian Goh
NPI 1629508866
$23,360.10
in general payments reported to CMS, 2019-2025
14 companies · $16K in 2025
The $16K reported for 2025 was more than what 76% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $494 · 2022: $1,449 · 2023: $1,216 · 2024: $4,476 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Travel and Lodging: $8,315 · Food and Beverage: $4,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Travel and Lodging | $8,315.17 |
| Food and Beverage | $4,102.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteocentric Technologies, INC. | $11,509.04 | 2023-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Alphatec Spine, INC | $4,993.60 | 2022-2025 | Other - Miscellaneous, Lif |
| Medical Device Business Services, INC. | $1,398.81 | 2022-2024 | Teligen |
| United Orthopedics LLC | $1,190.68 | 2024-2025 | |
| Depuy Synthes Sales INC. | $1,046.90 | 2022-2024 | Teligen, Conduit, Expedium Verse |
| Stryker Corporation | $1,005.65 | 2021-2022 | |
| Medtronic, INC. | $710.10 | 2021-2025 | Unid_pass, Prestige LP Cervical Disc System, Stealthstation S8 Platform |
| Cerapedics INC. | $567.92 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Arthrex, INC. | $365.90 | 2024 | |
| Kuros Biosciences USA, INC | $263.94 | 2024 | Magnetos |
| Kyocera Medical Technologies, INC. | $203.75 | 2022-2023 | |
| Biocomposites INC | $52.09 | 2024 | |
| Celgene Corporation | $29.59 | 2023-2025 | Reblozyl, Pomalyst |
| Heron Therapeutics, INC. | $22.13 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Goh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.